nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—SLC6A4—Alzheimer's disease	0.195	0.587	CbGaD
Citalopram—CYP2D6—Alzheimer's disease	0.137	0.413	CbGaD
Citalopram—CYP2B6—Memantine—Alzheimer's disease	0.0726	0.234	CbGbCtD
Citalopram—CYP2D6—Rivastigmine—Alzheimer's disease	0.0506	0.163	CbGbCtD
Citalopram—CYP2C19—Memantine—Alzheimer's disease	0.0461	0.149	CbGbCtD
Citalopram—CYP2D6—Donepezil—Alzheimer's disease	0.0404	0.13	CbGbCtD
Citalopram—CYP3A4—Rivastigmine—Alzheimer's disease	0.0322	0.104	CbGbCtD
Citalopram—CYP2D6—Galantamine—Alzheimer's disease	0.0261	0.084	CbGbCtD
Citalopram—CYP3A4—Donepezil—Alzheimer's disease	0.0257	0.0829	CbGbCtD
Citalopram—CYP3A4—Galantamine—Alzheimer's disease	0.0166	0.0534	CbGbCtD
Citalopram—HTR2C—choroid plexus—Alzheimer's disease	0.0109	0.231	CbGeAlD
Citalopram—SLC6A2—locus ceruleus—Alzheimer's disease	0.00563	0.119	CbGeAlD
Citalopram—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00331	0.0701	CbGeAlD
Citalopram—HTR2C—telencephalic ventricle—Alzheimer's disease	0.0032	0.0677	CbGeAlD
Citalopram—Escitalopram—SLC6A4—Alzheimer's disease	0.00181	0.587	CrCbGaD
Citalopram—Escitalopram—CYP2D6—Alzheimer's disease	0.00127	0.413	CrCbGaD
Citalopram—SLC6A3—forebrain—Alzheimer's disease	0.000864	0.0183	CbGeAlD
Citalopram—HTR2C—forebrain—Alzheimer's disease	0.000836	0.0177	CbGeAlD
Citalopram—SLC6A3—telencephalon—Alzheimer's disease	0.000795	0.0168	CbGeAlD
Citalopram—SLC6A4—forebrain—Alzheimer's disease	0.000792	0.0168	CbGeAlD
Citalopram—CHRM1—forebrain—Alzheimer's disease	0.000789	0.0167	CbGeAlD
Citalopram—HTR2C—telencephalon—Alzheimer's disease	0.000768	0.0163	CbGeAlD
Citalopram—SLC6A4—telencephalon—Alzheimer's disease	0.000728	0.0154	CbGeAlD
Citalopram—CHRM1—telencephalon—Alzheimer's disease	0.000726	0.0154	CbGeAlD
Citalopram—SLC6A2—forebrain—Alzheimer's disease	0.000697	0.0148	CbGeAlD
Citalopram—ADRA1A—forebrain—Alzheimer's disease	0.000648	0.0137	CbGeAlD
Citalopram—SLC6A2—telencephalon—Alzheimer's disease	0.000641	0.0136	CbGeAlD
Citalopram—ADRA1A—telencephalon—Alzheimer's disease	0.000596	0.0126	CbGeAlD
Citalopram—ABCB1—blood vessel—Alzheimer's disease	0.000521	0.011	CbGeAlD
Citalopram—HRH1—forebrain—Alzheimer's disease	0.000502	0.0106	CbGeAlD
Citalopram—SLC6A3—nervous system—Alzheimer's disease	0.000469	0.00993	CbGeAlD
Citalopram—HRH1—telencephalon—Alzheimer's disease	0.000461	0.00977	CbGeAlD
Citalopram—HTR2C—nervous system—Alzheimer's disease	0.000454	0.0096	CbGeAlD
Citalopram—SLC6A3—central nervous system—Alzheimer's disease	0.000452	0.00956	CbGeAlD
Citalopram—CYP2E1—telencephalon—Alzheimer's disease	0.000443	0.00938	CbGeAlD
Citalopram—SLC6A3—cerebellum—Alzheimer's disease	0.000442	0.00935	CbGeAlD
Citalopram—HTR2C—central nervous system—Alzheimer's disease	0.000437	0.00924	CbGeAlD
Citalopram—SLC6A4—nervous system—Alzheimer's disease	0.00043	0.0091	CbGeAlD
Citalopram—CHRM1—nervous system—Alzheimer's disease	0.000428	0.00907	CbGeAlD
Citalopram—SLC6A4—central nervous system—Alzheimer's disease	0.000414	0.00876	CbGeAlD
Citalopram—CHRM1—central nervous system—Alzheimer's disease	0.000412	0.00873	CbGeAlD
Citalopram—CYP2D6—forebrain—Alzheimer's disease	0.000382	0.00808	CbGeAlD
Citalopram—SLC6A2—nervous system—Alzheimer's disease	0.000379	0.00801	CbGeAlD
Citalopram—SLC6A2—central nervous system—Alzheimer's disease	0.000364	0.00771	CbGeAlD
Citalopram—SLC6A3—brain—Alzheimer's disease	0.000359	0.00759	CbGeAlD
Citalopram—ADRA1A—nervous system—Alzheimer's disease	0.000352	0.00745	CbGeAlD
Citalopram—CYP2D6—telencephalon—Alzheimer's disease	0.000351	0.00743	CbGeAlD
Citalopram—HTR2C—brain—Alzheimer's disease	0.000347	0.00734	CbGeAlD
Citalopram—ADRA1A—central nervous system—Alzheimer's disease	0.000339	0.00717	CbGeAlD
Citalopram—ADRA1A—cerebellum—Alzheimer's disease	0.000331	0.00701	CbGeAlD
Citalopram—SLC6A4—brain—Alzheimer's disease	0.000329	0.00696	CbGeAlD
Citalopram—CHRM1—brain—Alzheimer's disease	0.000327	0.00693	CbGeAlD
Citalopram—ABCB1—embryo—Alzheimer's disease	0.000311	0.00657	CbGeAlD
Citalopram—SLC6A2—brain—Alzheimer's disease	0.000289	0.00612	CbGeAlD
Citalopram—CYP2B6—nervous system—Alzheimer's disease	0.000279	0.0059	CbGeAlD
Citalopram—ABCB1—forebrain—Alzheimer's disease	0.000275	0.00581	CbGeAlD
Citalopram—HRH1—nervous system—Alzheimer's disease	0.000272	0.00577	CbGeAlD
Citalopram—ADRA1A—brain—Alzheimer's disease	0.000269	0.00569	CbGeAlD
Citalopram—CYP2B6—central nervous system—Alzheimer's disease	0.000269	0.00568	CbGeAlD
Citalopram—HRH1—central nervous system—Alzheimer's disease	0.000262	0.00555	CbGeAlD
Citalopram—CYP2E1—nervous system—Alzheimer's disease	0.000262	0.00554	CbGeAlD
Citalopram—ABCB1—telencephalon—Alzheimer's disease	0.000253	0.00535	CbGeAlD
Citalopram—CYP2E1—central nervous system—Alzheimer's disease	0.000252	0.00533	CbGeAlD
Citalopram—CYP2E1—cerebellum—Alzheimer's disease	0.000246	0.00521	CbGeAlD
Citalopram—CYP2B6—brain—Alzheimer's disease	0.000213	0.00451	CbGeAlD
Citalopram—CYP3A4—nervous system—Alzheimer's disease	0.000211	0.00446	CbGeAlD
Citalopram—HRH1—brain—Alzheimer's disease	0.000208	0.00441	CbGeAlD
Citalopram—CYP2D6—nervous system—Alzheimer's disease	0.000207	0.00439	CbGeAlD
Citalopram—CYP3A4—central nervous system—Alzheimer's disease	0.000203	0.00429	CbGeAlD
Citalopram—CYP2E1—brain—Alzheimer's disease	0.0002	0.00423	CbGeAlD
Citalopram—CYP2D6—central nervous system—Alzheimer's disease	0.0002	0.00422	CbGeAlD
Citalopram—CYP2D6—cerebellum—Alzheimer's disease	0.000195	0.00413	CbGeAlD
Citalopram—CYP2D6—brain—Alzheimer's disease	0.000158	0.00335	CbGeAlD
Citalopram—ABCB1—nervous system—Alzheimer's disease	0.000149	0.00316	CbGeAlD
Citalopram—ABCB1—central nervous system—Alzheimer's disease	0.000144	0.00304	CbGeAlD
Citalopram—ABCB1—cerebellum—Alzheimer's disease	0.00014	0.00297	CbGeAlD
Citalopram—ABCB1—brain—Alzheimer's disease	0.000114	0.00241	CbGeAlD
Citalopram—Haemorrhage—Rivastigmine—Alzheimer's disease	8.28e-05	0.000331	CcSEcCtD
Citalopram—Hepatitis—Rivastigmine—Alzheimer's disease	8.28e-05	0.000331	CcSEcCtD
Citalopram—Hyperhidrosis—Galantamine—Alzheimer's disease	8.26e-05	0.000331	CcSEcCtD
Citalopram—Hypoaesthesia—Rivastigmine—Alzheimer's disease	8.23e-05	0.00033	CcSEcCtD
Citalopram—Hallucination—Rivastigmine—Alzheimer's disease	8.23e-05	0.00033	CcSEcCtD
Citalopram—Alopecia—Donepezil—Alzheimer's disease	8.23e-05	0.00033	CcSEcCtD
Citalopram—Pharyngitis—Rivastigmine—Alzheimer's disease	8.21e-05	0.000329	CcSEcCtD
Citalopram—Urinary tract disorder—Rivastigmine—Alzheimer's disease	8.17e-05	0.000327	CcSEcCtD
Citalopram—Mental disorder—Donepezil—Alzheimer's disease	8.16e-05	0.000327	CcSEcCtD
Citalopram—Oedema peripheral—Rivastigmine—Alzheimer's disease	8.15e-05	0.000326	CcSEcCtD
Citalopram—Visual impairment—Memantine—Alzheimer's disease	8.15e-05	0.000326	CcSEcCtD
Citalopram—Anorexia—Galantamine—Alzheimer's disease	8.14e-05	0.000326	CcSEcCtD
Citalopram—Connective tissue disorder—Rivastigmine—Alzheimer's disease	8.13e-05	0.000326	CcSEcCtD
Citalopram—Urethral disorder—Rivastigmine—Alzheimer's disease	8.11e-05	0.000325	CcSEcCtD
Citalopram—Erythema—Donepezil—Alzheimer's disease	8.11e-05	0.000325	CcSEcCtD
Citalopram—Malnutrition—Donepezil—Alzheimer's disease	8.11e-05	0.000325	CcSEcCtD
Citalopram—Erythema multiforme—Memantine—Alzheimer's disease	8e-05	0.00032	CcSEcCtD
Citalopram—Flatulence—Donepezil—Alzheimer's disease	7.99e-05	0.00032	CcSEcCtD
Citalopram—Hypotension—Galantamine—Alzheimer's disease	7.98e-05	0.000319	CcSEcCtD
Citalopram—Visual impairment—Rivastigmine—Alzheimer's disease	7.97e-05	0.000319	CcSEcCtD
Citalopram—Tension—Donepezil—Alzheimer's disease	7.96e-05	0.000319	CcSEcCtD
Citalopram—Dysgeusia—Donepezil—Alzheimer's disease	7.94e-05	0.000318	CcSEcCtD
Citalopram—Eye disorder—Memantine—Alzheimer's disease	7.9e-05	0.000316	CcSEcCtD
Citalopram—Tinnitus—Memantine—Alzheimer's disease	7.89e-05	0.000316	CcSEcCtD
Citalopram—Nervousness—Donepezil—Alzheimer's disease	7.88e-05	0.000315	CcSEcCtD
Citalopram—Cardiac disorder—Memantine—Alzheimer's disease	7.85e-05	0.000314	CcSEcCtD
Citalopram—Flushing—Memantine—Alzheimer's disease	7.85e-05	0.000314	CcSEcCtD
Citalopram—Back pain—Donepezil—Alzheimer's disease	7.84e-05	0.000314	CcSEcCtD
Citalopram—Erythema multiforme—Rivastigmine—Alzheimer's disease	7.82e-05	0.000313	CcSEcCtD
Citalopram—Muscle spasms—Donepezil—Alzheimer's disease	7.8e-05	0.000312	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	7.78e-05	0.000311	CcSEcCtD
Citalopram—Eye disorder—Rivastigmine—Alzheimer's disease	7.73e-05	0.00031	CcSEcCtD
Citalopram—Insomnia—Galantamine—Alzheimer's disease	7.72e-05	0.000309	CcSEcCtD
Citalopram—Tinnitus—Rivastigmine—Alzheimer's disease	7.72e-05	0.000309	CcSEcCtD
Citalopram—Flushing—Rivastigmine—Alzheimer's disease	7.68e-05	0.000307	CcSEcCtD
Citalopram—Cardiac disorder—Rivastigmine—Alzheimer's disease	7.68e-05	0.000307	CcSEcCtD
Citalopram—Angiopathy—Memantine—Alzheimer's disease	7.67e-05	0.000307	CcSEcCtD
Citalopram—Paraesthesia—Galantamine—Alzheimer's disease	7.67e-05	0.000307	CcSEcCtD
Citalopram—Vision blurred—Donepezil—Alzheimer's disease	7.64e-05	0.000306	CcSEcCtD
Citalopram—Immune system disorder—Memantine—Alzheimer's disease	7.64e-05	0.000306	CcSEcCtD
Citalopram—Mediastinal disorder—Memantine—Alzheimer's disease	7.62e-05	0.000305	CcSEcCtD
Citalopram—Tremor—Donepezil—Alzheimer's disease	7.6e-05	0.000304	CcSEcCtD
Citalopram—Somnolence—Galantamine—Alzheimer's disease	7.59e-05	0.000304	CcSEcCtD
Citalopram—Chills—Memantine—Alzheimer's disease	7.59e-05	0.000304	CcSEcCtD
Citalopram—Arrhythmia—Memantine—Alzheimer's disease	7.56e-05	0.000303	CcSEcCtD
Citalopram—Ill-defined disorder—Donepezil—Alzheimer's disease	7.52e-05	0.000301	CcSEcCtD
Citalopram—Dyspepsia—Galantamine—Alzheimer's disease	7.52e-05	0.000301	CcSEcCtD
Citalopram—Angiopathy—Rivastigmine—Alzheimer's disease	7.51e-05	0.000301	CcSEcCtD
Citalopram—Anaemia—Donepezil—Alzheimer's disease	7.5e-05	0.0003	CcSEcCtD
Citalopram—Alopecia—Memantine—Alzheimer's disease	7.47e-05	0.000299	CcSEcCtD
Citalopram—Mediastinal disorder—Rivastigmine—Alzheimer's disease	7.46e-05	0.000299	CcSEcCtD
Citalopram—Agitation—Donepezil—Alzheimer's disease	7.45e-05	0.000298	CcSEcCtD
Citalopram—Chills—Rivastigmine—Alzheimer's disease	7.42e-05	0.000297	CcSEcCtD
Citalopram—Decreased appetite—Galantamine—Alzheimer's disease	7.42e-05	0.000297	CcSEcCtD
Citalopram—Mental disorder—Memantine—Alzheimer's disease	7.41e-05	0.000297	CcSEcCtD
Citalopram—Arrhythmia—Rivastigmine—Alzheimer's disease	7.39e-05	0.000296	CcSEcCtD
Citalopram—Gastrointestinal disorder—Galantamine—Alzheimer's disease	7.37e-05	0.000295	CcSEcCtD
Citalopram—Malnutrition—Memantine—Alzheimer's disease	7.36e-05	0.000295	CcSEcCtD
Citalopram—Fatigue—Galantamine—Alzheimer's disease	7.36e-05	0.000295	CcSEcCtD
Citalopram—Malaise—Donepezil—Alzheimer's disease	7.31e-05	0.000293	CcSEcCtD
Citalopram—Alopecia—Rivastigmine—Alzheimer's disease	7.31e-05	0.000293	CcSEcCtD
Citalopram—Constipation—Galantamine—Alzheimer's disease	7.3e-05	0.000292	CcSEcCtD
Citalopram—Vertigo—Donepezil—Alzheimer's disease	7.29e-05	0.000292	CcSEcCtD
Citalopram—Syncope—Donepezil—Alzheimer's disease	7.27e-05	0.000291	CcSEcCtD
Citalopram—Flatulence—Memantine—Alzheimer's disease	7.26e-05	0.00029	CcSEcCtD
Citalopram—Mental disorder—Rivastigmine—Alzheimer's disease	7.25e-05	0.00029	CcSEcCtD
Citalopram—Tension—Memantine—Alzheimer's disease	7.23e-05	0.000289	CcSEcCtD
Citalopram—Dysgeusia—Memantine—Alzheimer's disease	7.21e-05	0.000289	CcSEcCtD
Citalopram—Erythema—Rivastigmine—Alzheimer's disease	7.2e-05	0.000288	CcSEcCtD
Citalopram—Malnutrition—Rivastigmine—Alzheimer's disease	7.2e-05	0.000288	CcSEcCtD
Citalopram—Nervousness—Memantine—Alzheimer's disease	7.15e-05	0.000286	CcSEcCtD
Citalopram—Loss of consciousness—Donepezil—Alzheimer's disease	7.13e-05	0.000285	CcSEcCtD
Citalopram—Back pain—Memantine—Alzheimer's disease	7.12e-05	0.000285	CcSEcCtD
Citalopram—Flatulence—Rivastigmine—Alzheimer's disease	7.1e-05	0.000284	CcSEcCtD
Citalopram—Cough—Donepezil—Alzheimer's disease	7.08e-05	0.000283	CcSEcCtD
Citalopram—Tension—Rivastigmine—Alzheimer's disease	7.07e-05	0.000283	CcSEcCtD
Citalopram—Dysgeusia—Rivastigmine—Alzheimer's disease	7.05e-05	0.000282	CcSEcCtD
Citalopram—Feeling abnormal—Galantamine—Alzheimer's disease	7.04e-05	0.000282	CcSEcCtD
Citalopram—Convulsion—Donepezil—Alzheimer's disease	7.03e-05	0.000281	CcSEcCtD
Citalopram—Hypertension—Donepezil—Alzheimer's disease	7e-05	0.00028	CcSEcCtD
Citalopram—Nervousness—Rivastigmine—Alzheimer's disease	7e-05	0.00028	CcSEcCtD
Citalopram—Gastrointestinal pain—Galantamine—Alzheimer's disease	6.98e-05	0.00028	CcSEcCtD
Citalopram—Back pain—Rivastigmine—Alzheimer's disease	6.97e-05	0.000279	CcSEcCtD
Citalopram—Vision blurred—Memantine—Alzheimer's disease	6.94e-05	0.000278	CcSEcCtD
Citalopram—Muscle spasms—Rivastigmine—Alzheimer's disease	6.93e-05	0.000277	CcSEcCtD
Citalopram—Chest pain—Donepezil—Alzheimer's disease	6.9e-05	0.000276	CcSEcCtD
Citalopram—Arthralgia—Donepezil—Alzheimer's disease	6.9e-05	0.000276	CcSEcCtD
Citalopram—Myalgia—Donepezil—Alzheimer's disease	6.9e-05	0.000276	CcSEcCtD
Citalopram—Tremor—Memantine—Alzheimer's disease	6.9e-05	0.000276	CcSEcCtD
Citalopram—Anxiety—Donepezil—Alzheimer's disease	6.88e-05	0.000275	CcSEcCtD
Citalopram—Ill-defined disorder—Memantine—Alzheimer's disease	6.83e-05	0.000274	CcSEcCtD
Citalopram—Discomfort—Donepezil—Alzheimer's disease	6.82e-05	0.000273	CcSEcCtD
Citalopram—Anaemia—Memantine—Alzheimer's disease	6.81e-05	0.000272	CcSEcCtD
Citalopram—Vision blurred—Rivastigmine—Alzheimer's disease	6.79e-05	0.000272	CcSEcCtD
Citalopram—Agitation—Memantine—Alzheimer's disease	6.77e-05	0.000271	CcSEcCtD
Citalopram—Dry mouth—Donepezil—Alzheimer's disease	6.75e-05	0.00027	CcSEcCtD
Citalopram—Abdominal pain—Galantamine—Alzheimer's disease	6.75e-05	0.00027	CcSEcCtD
Citalopram—Body temperature increased—Galantamine—Alzheimer's disease	6.75e-05	0.00027	CcSEcCtD
Citalopram—Tremor—Rivastigmine—Alzheimer's disease	6.75e-05	0.00027	CcSEcCtD
Citalopram—Ill-defined disorder—Rivastigmine—Alzheimer's disease	6.68e-05	0.000268	CcSEcCtD
Citalopram—Confusional state—Donepezil—Alzheimer's disease	6.67e-05	0.000267	CcSEcCtD
Citalopram—Anaemia—Rivastigmine—Alzheimer's disease	6.66e-05	0.000267	CcSEcCtD
Citalopram—Malaise—Memantine—Alzheimer's disease	6.64e-05	0.000266	CcSEcCtD
Citalopram—Agitation—Rivastigmine—Alzheimer's disease	6.62e-05	0.000265	CcSEcCtD
Citalopram—Oedema—Donepezil—Alzheimer's disease	6.62e-05	0.000265	CcSEcCtD
Citalopram—Vertigo—Memantine—Alzheimer's disease	6.62e-05	0.000265	CcSEcCtD
Citalopram—Syncope—Memantine—Alzheimer's disease	6.6e-05	0.000264	CcSEcCtD
Citalopram—Leukopenia—Memantine—Alzheimer's disease	6.59e-05	0.000264	CcSEcCtD
Citalopram—Infection—Donepezil—Alzheimer's disease	6.58e-05	0.000263	CcSEcCtD
Citalopram—Shock—Donepezil—Alzheimer's disease	6.51e-05	0.000261	CcSEcCtD
Citalopram—Palpitations—Memantine—Alzheimer's disease	6.51e-05	0.00026	CcSEcCtD
Citalopram—Malaise—Rivastigmine—Alzheimer's disease	6.5e-05	0.00026	CcSEcCtD
Citalopram—Nervous system disorder—Donepezil—Alzheimer's disease	6.49e-05	0.00026	CcSEcCtD
Citalopram—Thrombocytopenia—Donepezil—Alzheimer's disease	6.48e-05	0.000259	CcSEcCtD
Citalopram—Vertigo—Rivastigmine—Alzheimer's disease	6.47e-05	0.000259	CcSEcCtD
Citalopram—Loss of consciousness—Memantine—Alzheimer's disease	6.47e-05	0.000259	CcSEcCtD
Citalopram—Syncope—Rivastigmine—Alzheimer's disease	6.46e-05	0.000259	CcSEcCtD
Citalopram—Cough—Memantine—Alzheimer's disease	6.43e-05	0.000257	CcSEcCtD
Citalopram—Hyperhidrosis—Donepezil—Alzheimer's disease	6.4e-05	0.000256	CcSEcCtD
Citalopram—Convulsion—Memantine—Alzheimer's disease	6.38e-05	0.000255	CcSEcCtD
Citalopram—Palpitations—Rivastigmine—Alzheimer's disease	6.37e-05	0.000255	CcSEcCtD
Citalopram—Hypertension—Memantine—Alzheimer's disease	6.36e-05	0.000254	CcSEcCtD
Citalopram—Loss of consciousness—Rivastigmine—Alzheimer's disease	6.33e-05	0.000253	CcSEcCtD
Citalopram—Anorexia—Donepezil—Alzheimer's disease	6.31e-05	0.000253	CcSEcCtD
Citalopram—Hypersensitivity—Galantamine—Alzheimer's disease	6.29e-05	0.000252	CcSEcCtD
Citalopram—Cough—Rivastigmine—Alzheimer's disease	6.29e-05	0.000252	CcSEcCtD
Citalopram—Chest pain—Memantine—Alzheimer's disease	6.27e-05	0.000251	CcSEcCtD
Citalopram—Arthralgia—Memantine—Alzheimer's disease	6.27e-05	0.000251	CcSEcCtD
Citalopram—Myalgia—Memantine—Alzheimer's disease	6.27e-05	0.000251	CcSEcCtD
Citalopram—Anxiety—Memantine—Alzheimer's disease	6.25e-05	0.00025	CcSEcCtD
Citalopram—Convulsion—Rivastigmine—Alzheimer's disease	6.24e-05	0.00025	CcSEcCtD
Citalopram—Hypertension—Rivastigmine—Alzheimer's disease	6.22e-05	0.000249	CcSEcCtD
Citalopram—Discomfort—Memantine—Alzheimer's disease	6.19e-05	0.000248	CcSEcCtD
Citalopram—Hypotension—Donepezil—Alzheimer's disease	6.18e-05	0.000248	CcSEcCtD
Citalopram—Chest pain—Rivastigmine—Alzheimer's disease	6.13e-05	0.000246	CcSEcCtD
Citalopram—Myalgia—Rivastigmine—Alzheimer's disease	6.13e-05	0.000246	CcSEcCtD
Citalopram—Arthralgia—Rivastigmine—Alzheimer's disease	6.13e-05	0.000246	CcSEcCtD
Citalopram—Dry mouth—Memantine—Alzheimer's disease	6.13e-05	0.000245	CcSEcCtD
Citalopram—Asthenia—Galantamine—Alzheimer's disease	6.13e-05	0.000245	CcSEcCtD
Citalopram—Anxiety—Rivastigmine—Alzheimer's disease	6.11e-05	0.000245	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	6.09e-05	0.000244	CcSEcCtD
Citalopram—Confusional state—Memantine—Alzheimer's disease	6.06e-05	0.000243	CcSEcCtD
Citalopram—Discomfort—Rivastigmine—Alzheimer's disease	6.06e-05	0.000243	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	6.03e-05	0.000241	CcSEcCtD
Citalopram—Oedema—Memantine—Alzheimer's disease	6.01e-05	0.000241	CcSEcCtD
Citalopram—Dry mouth—Rivastigmine—Alzheimer's disease	6e-05	0.00024	CcSEcCtD
Citalopram—Insomnia—Donepezil—Alzheimer's disease	5.99e-05	0.00024	CcSEcCtD
Citalopram—Infection—Memantine—Alzheimer's disease	5.97e-05	0.000239	CcSEcCtD
Citalopram—Paraesthesia—Donepezil—Alzheimer's disease	5.94e-05	0.000238	CcSEcCtD
Citalopram—Confusional state—Rivastigmine—Alzheimer's disease	5.93e-05	0.000237	CcSEcCtD
Citalopram—Shock—Memantine—Alzheimer's disease	5.91e-05	0.000237	CcSEcCtD
Citalopram—Dyspnoea—Donepezil—Alzheimer's disease	5.9e-05	0.000236	CcSEcCtD
Citalopram—Nervous system disorder—Memantine—Alzheimer's disease	5.89e-05	0.000236	CcSEcCtD
Citalopram—Somnolence—Donepezil—Alzheimer's disease	5.88e-05	0.000236	CcSEcCtD
Citalopram—Thrombocytopenia—Memantine—Alzheimer's disease	5.88e-05	0.000236	CcSEcCtD
Citalopram—Oedema—Rivastigmine—Alzheimer's disease	5.88e-05	0.000235	CcSEcCtD
Citalopram—Tachycardia—Memantine—Alzheimer's disease	5.87e-05	0.000235	CcSEcCtD
Citalopram—Diarrhoea—Galantamine—Alzheimer's disease	5.84e-05	0.000234	CcSEcCtD
Citalopram—Infection—Rivastigmine—Alzheimer's disease	5.84e-05	0.000234	CcSEcCtD
Citalopram—Skin disorder—Memantine—Alzheimer's disease	5.84e-05	0.000234	CcSEcCtD
Citalopram—Dyspepsia—Donepezil—Alzheimer's disease	5.83e-05	0.000233	CcSEcCtD
Citalopram—Hyperhidrosis—Memantine—Alzheimer's disease	5.81e-05	0.000233	CcSEcCtD
Citalopram—Shock—Rivastigmine—Alzheimer's disease	5.78e-05	0.000232	CcSEcCtD
Citalopram—Nervous system disorder—Rivastigmine—Alzheimer's disease	5.77e-05	0.000231	CcSEcCtD
Citalopram—Thrombocytopenia—Rivastigmine—Alzheimer's disease	5.76e-05	0.00023	CcSEcCtD
Citalopram—Decreased appetite—Donepezil—Alzheimer's disease	5.75e-05	0.00023	CcSEcCtD
Citalopram—Tachycardia—Rivastigmine—Alzheimer's disease	5.74e-05	0.00023	CcSEcCtD
Citalopram—Anorexia—Memantine—Alzheimer's disease	5.73e-05	0.000229	CcSEcCtD
Citalopram—Gastrointestinal disorder—Donepezil—Alzheimer's disease	5.71e-05	0.000229	CcSEcCtD
Citalopram—Skin disorder—Rivastigmine—Alzheimer's disease	5.71e-05	0.000229	CcSEcCtD
Citalopram—Fatigue—Donepezil—Alzheimer's disease	5.71e-05	0.000228	CcSEcCtD
Citalopram—Hyperhidrosis—Rivastigmine—Alzheimer's disease	5.68e-05	0.000228	CcSEcCtD
Citalopram—Constipation—Donepezil—Alzheimer's disease	5.66e-05	0.000227	CcSEcCtD
Citalopram—Pain—Donepezil—Alzheimer's disease	5.66e-05	0.000227	CcSEcCtD
Citalopram—Dizziness—Galantamine—Alzheimer's disease	5.65e-05	0.000226	CcSEcCtD
Citalopram—Hypotension—Memantine—Alzheimer's disease	5.62e-05	0.000225	CcSEcCtD
Citalopram—Anorexia—Rivastigmine—Alzheimer's disease	5.6e-05	0.000224	CcSEcCtD
Citalopram—Hypotension—Rivastigmine—Alzheimer's disease	5.49e-05	0.00022	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Memantine—Alzheimer's disease	5.48e-05	0.000219	CcSEcCtD
Citalopram—Feeling abnormal—Donepezil—Alzheimer's disease	5.45e-05	0.000218	CcSEcCtD
Citalopram—Insomnia—Memantine—Alzheimer's disease	5.44e-05	0.000218	CcSEcCtD
Citalopram—Vomiting—Galantamine—Alzheimer's disease	5.43e-05	0.000217	CcSEcCtD
Citalopram—Gastrointestinal pain—Donepezil—Alzheimer's disease	5.41e-05	0.000217	CcSEcCtD
Citalopram—Paraesthesia—Memantine—Alzheimer's disease	5.4e-05	0.000216	CcSEcCtD
Citalopram—Rash—Galantamine—Alzheimer's disease	5.38e-05	0.000216	CcSEcCtD
Citalopram—Dermatitis—Galantamine—Alzheimer's disease	5.38e-05	0.000215	CcSEcCtD
Citalopram—Dyspnoea—Memantine—Alzheimer's disease	5.36e-05	0.000214	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	5.36e-05	0.000214	CcSEcCtD
Citalopram—Headache—Galantamine—Alzheimer's disease	5.35e-05	0.000214	CcSEcCtD
Citalopram—Somnolence—Memantine—Alzheimer's disease	5.34e-05	0.000214	CcSEcCtD
Citalopram—Insomnia—Rivastigmine—Alzheimer's disease	5.32e-05	0.000213	CcSEcCtD
Citalopram—Dyspepsia—Memantine—Alzheimer's disease	5.29e-05	0.000212	CcSEcCtD
Citalopram—Paraesthesia—Rivastigmine—Alzheimer's disease	5.28e-05	0.000211	CcSEcCtD
Citalopram—Urticaria—Donepezil—Alzheimer's disease	5.26e-05	0.00021	CcSEcCtD
Citalopram—Dyspnoea—Rivastigmine—Alzheimer's disease	5.24e-05	0.00021	CcSEcCtD
Citalopram—Abdominal pain—Donepezil—Alzheimer's disease	5.23e-05	0.000209	CcSEcCtD
Citalopram—Body temperature increased—Donepezil—Alzheimer's disease	5.23e-05	0.000209	CcSEcCtD
Citalopram—Somnolence—Rivastigmine—Alzheimer's disease	5.23e-05	0.000209	CcSEcCtD
Citalopram—Decreased appetite—Memantine—Alzheimer's disease	5.22e-05	0.000209	CcSEcCtD
Citalopram—Gastrointestinal disorder—Memantine—Alzheimer's disease	5.19e-05	0.000208	CcSEcCtD
Citalopram—Fatigue—Memantine—Alzheimer's disease	5.18e-05	0.000207	CcSEcCtD
Citalopram—Dyspepsia—Rivastigmine—Alzheimer's disease	5.18e-05	0.000207	CcSEcCtD
Citalopram—Constipation—Memantine—Alzheimer's disease	5.14e-05	0.000206	CcSEcCtD
Citalopram—Pain—Memantine—Alzheimer's disease	5.14e-05	0.000206	CcSEcCtD
Citalopram—Decreased appetite—Rivastigmine—Alzheimer's disease	5.11e-05	0.000205	CcSEcCtD
Citalopram—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	5.08e-05	0.000203	CcSEcCtD
Citalopram—Nausea—Galantamine—Alzheimer's disease	5.07e-05	0.000203	CcSEcCtD
Citalopram—Fatigue—Rivastigmine—Alzheimer's disease	5.07e-05	0.000203	CcSEcCtD
Citalopram—Pain—Rivastigmine—Alzheimer's disease	5.03e-05	0.000201	CcSEcCtD
Citalopram—Constipation—Rivastigmine—Alzheimer's disease	5.03e-05	0.000201	CcSEcCtD
Citalopram—Feeling abnormal—Memantine—Alzheimer's disease	4.95e-05	0.000198	CcSEcCtD
Citalopram—Gastrointestinal pain—Memantine—Alzheimer's disease	4.91e-05	0.000197	CcSEcCtD
Citalopram—Hypersensitivity—Donepezil—Alzheimer's disease	4.88e-05	0.000195	CcSEcCtD
Citalopram—Feeling abnormal—Rivastigmine—Alzheimer's disease	4.84e-05	0.000194	CcSEcCtD
Citalopram—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	4.81e-05	0.000192	CcSEcCtD
Citalopram—Urticaria—Memantine—Alzheimer's disease	4.77e-05	0.000191	CcSEcCtD
Citalopram—Abdominal pain—Memantine—Alzheimer's disease	4.75e-05	0.00019	CcSEcCtD
Citalopram—Body temperature increased—Memantine—Alzheimer's disease	4.75e-05	0.00019	CcSEcCtD
Citalopram—Asthenia—Donepezil—Alzheimer's disease	4.75e-05	0.00019	CcSEcCtD
Citalopram—Pruritus—Donepezil—Alzheimer's disease	4.68e-05	0.000187	CcSEcCtD
Citalopram—Urticaria—Rivastigmine—Alzheimer's disease	4.67e-05	0.000187	CcSEcCtD
Citalopram—Abdominal pain—Rivastigmine—Alzheimer's disease	4.65e-05	0.000186	CcSEcCtD
Citalopram—Body temperature increased—Rivastigmine—Alzheimer's disease	4.65e-05	0.000186	CcSEcCtD
Citalopram—Diarrhoea—Donepezil—Alzheimer's disease	4.53e-05	0.000181	CcSEcCtD
Citalopram—Hypersensitivity—Memantine—Alzheimer's disease	4.43e-05	0.000177	CcSEcCtD
Citalopram—Dizziness—Donepezil—Alzheimer's disease	4.38e-05	0.000175	CcSEcCtD
Citalopram—Hypersensitivity—Rivastigmine—Alzheimer's disease	4.33e-05	0.000173	CcSEcCtD
Citalopram—Asthenia—Memantine—Alzheimer's disease	4.31e-05	0.000173	CcSEcCtD
Citalopram—Pruritus—Memantine—Alzheimer's disease	4.25e-05	0.00017	CcSEcCtD
Citalopram—Asthenia—Rivastigmine—Alzheimer's disease	4.22e-05	0.000169	CcSEcCtD
Citalopram—Vomiting—Donepezil—Alzheimer's disease	4.21e-05	0.000168	CcSEcCtD
Citalopram—Rash—Donepezil—Alzheimer's disease	4.17e-05	0.000167	CcSEcCtD
Citalopram—Dermatitis—Donepezil—Alzheimer's disease	4.17e-05	0.000167	CcSEcCtD
Citalopram—Pruritus—Rivastigmine—Alzheimer's disease	4.16e-05	0.000167	CcSEcCtD
Citalopram—Headache—Donepezil—Alzheimer's disease	4.15e-05	0.000166	CcSEcCtD
Citalopram—Diarrhoea—Memantine—Alzheimer's disease	4.11e-05	0.000165	CcSEcCtD
Citalopram—Diarrhoea—Rivastigmine—Alzheimer's disease	4.02e-05	0.000161	CcSEcCtD
Citalopram—Dizziness—Memantine—Alzheimer's disease	3.97e-05	0.000159	CcSEcCtD
Citalopram—Nausea—Donepezil—Alzheimer's disease	3.93e-05	0.000157	CcSEcCtD
Citalopram—Dizziness—Rivastigmine—Alzheimer's disease	3.89e-05	0.000156	CcSEcCtD
Citalopram—Vomiting—Memantine—Alzheimer's disease	3.82e-05	0.000153	CcSEcCtD
Citalopram—Rash—Memantine—Alzheimer's disease	3.79e-05	0.000152	CcSEcCtD
Citalopram—Dermatitis—Memantine—Alzheimer's disease	3.79e-05	0.000152	CcSEcCtD
Citalopram—Headache—Memantine—Alzheimer's disease	3.76e-05	0.000151	CcSEcCtD
Citalopram—Vomiting—Rivastigmine—Alzheimer's disease	3.74e-05	0.00015	CcSEcCtD
Citalopram—Rash—Rivastigmine—Alzheimer's disease	3.71e-05	0.000148	CcSEcCtD
Citalopram—Dermatitis—Rivastigmine—Alzheimer's disease	3.7e-05	0.000148	CcSEcCtD
Citalopram—Headache—Rivastigmine—Alzheimer's disease	3.68e-05	0.000147	CcSEcCtD
Citalopram—Nausea—Memantine—Alzheimer's disease	3.57e-05	0.000143	CcSEcCtD
Citalopram—Nausea—Rivastigmine—Alzheimer's disease	3.49e-05	0.00014	CcSEcCtD
Citalopram—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	5.98e-06	0.000105	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—S100B—Alzheimer's disease	5.97e-06	0.000105	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.97e-06	0.000105	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ENO1—Alzheimer's disease	5.95e-06	0.000104	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS1—Alzheimer's disease	5.95e-06	0.000104	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	5.95e-06	0.000104	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	5.92e-06	0.000104	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	5.91e-06	0.000104	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.91e-06	0.000104	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	5.91e-06	0.000104	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	5.89e-06	0.000103	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	5.85e-06	0.000103	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	5.84e-06	0.000102	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—A2M—Alzheimer's disease	5.83e-06	0.000102	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	5.79e-06	0.000101	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	5.77e-06	0.000101	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	5.76e-06	0.000101	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	5.68e-06	9.95e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—BCHE—Alzheimer's disease	5.67e-06	9.93e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	5.66e-06	9.92e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ENO1—Alzheimer's disease	5.61e-06	9.82e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	5.61e-06	9.82e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	5.6e-06	9.81e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	5.57e-06	9.76e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—BCHE—Alzheimer's disease	5.53e-06	9.69e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	5.49e-06	9.62e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	5.48e-06	9.6e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	5.48e-06	9.59e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	5.39e-06	9.44e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—LPL—Alzheimer's disease	5.38e-06	9.43e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	5.35e-06	9.37e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—LPL—Alzheimer's disease	5.27e-06	9.24e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—LPL—Alzheimer's disease	5.27e-06	9.22e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	5.25e-06	9.19e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.25e-06	9.19e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PLCB1—Alzheimer's disease	5.22e-06	9.14e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	5.22e-06	9.14e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.21e-06	9.13e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	5.2e-06	9.11e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.2e-06	9.1e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	5.18e-06	9.08e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	5.17e-06	9.05e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	5.12e-06	8.97e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	5.12e-06	8.97e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	5.11e-06	8.95e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	5.1e-06	8.94e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	5.09e-06	8.92e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	5.09e-06	8.92e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ACHE—Alzheimer's disease	5.07e-06	8.88e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ABCA1—Alzheimer's disease	5.06e-06	8.86e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	5.05e-06	8.84e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.05e-06	8.84e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.05e-06	8.84e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	5.02e-06	8.8e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	5.01e-06	8.78e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NGF—Alzheimer's disease	4.99e-06	8.74e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	4.97e-06	8.71e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.92e-06	8.62e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	4.89e-06	8.57e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	4.86e-06	8.52e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	4.85e-06	8.5e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	4.85e-06	8.49e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.84e-06	8.47e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	4.84e-06	8.47e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—F2—Alzheimer's disease	4.8e-06	8.42e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.77e-06	8.35e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	4.76e-06	8.34e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.75e-06	8.32e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.75e-06	8.32e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	4.75e-06	8.32e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	4.75e-06	8.32e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	4.73e-06	8.29e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	4.7e-06	8.23e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	4.66e-06	8.16e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	4.66e-06	8.16e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.66e-06	8.16e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CALM1—Alzheimer's disease	4.53e-06	7.93e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—APOE—Alzheimer's disease	4.51e-06	7.9e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.5e-06	7.88e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CAV1—Alzheimer's disease	4.47e-06	7.83e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	4.47e-06	7.83e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	4.45e-06	7.79e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CALM1—Alzheimer's disease	4.44e-06	7.77e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	4.43e-06	7.76e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—APOE—Alzheimer's disease	4.42e-06	7.74e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.42e-06	7.74e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	4.42e-06	7.73e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APOE—Alzheimer's disease	4.41e-06	7.73e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—LEP—Alzheimer's disease	4.41e-06	7.73e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.41e-06	7.73e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	4.4e-06	7.71e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	4.4e-06	7.71e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CAV1—Alzheimer's disease	4.38e-06	7.67e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.38e-06	7.67e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.37e-06	7.66e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	4.36e-06	7.64e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	4.36e-06	7.64e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.35e-06	7.62e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	4.35e-06	7.61e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.34e-06	7.6e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	4.33e-06	7.59e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	4.33e-06	7.59e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	4.29e-06	7.52e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.28e-06	7.5e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.21e-06	7.38e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	4.21e-06	7.37e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	4.2e-06	7.36e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.17e-06	7.3e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.16e-06	7.29e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—F2—Alzheimer's disease	4.15e-06	7.27e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	4.14e-06	7.24e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.11e-06	7.2e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.09e-06	7.17e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.09e-06	7.16e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	4.08e-06	7.16e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.07e-06	7.14e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—LPL—Alzheimer's disease	4.07e-06	7.13e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.06e-06	7.11e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4.04e-06	7.08e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	4e-06	7e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—LPL—Alzheimer's disease	3.97e-06	6.96e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PPARG—Alzheimer's disease	3.93e-06	6.88e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.91e-06	6.85e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.87e-06	6.77e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—INS—Alzheimer's disease	3.85e-06	6.75e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARG—Alzheimer's disease	3.85e-06	6.74e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	3.82e-06	6.7e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3.82e-06	6.69e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	3.81e-06	6.67e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.79e-06	6.64e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	3.78e-06	6.62e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—INS—Alzheimer's disease	3.78e-06	6.61e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.77e-06	6.61e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—INS—Alzheimer's disease	3.76e-06	6.58e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	3.75e-06	6.57e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.74e-06	6.55e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	3.72e-06	6.52e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.71e-06	6.5e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	3.7e-06	6.48e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	3.7e-06	6.48e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.67e-06	6.42e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.67e-06	6.42e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	3.66e-06	6.42e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.65e-06	6.39e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	3.64e-06	6.38e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	3.64e-06	6.37e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.6e-06	6.3e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	3.58e-06	6.27e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.58e-06	6.26e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.48e-06	6.1e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.47e-06	6.07e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.42e-06	5.99e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.41e-06	5.97e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.41e-06	5.97e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NOS3—Alzheimer's disease	3.38e-06	5.92e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.38e-06	5.92e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.37e-06	5.9e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.34e-06	5.85e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOE—Alzheimer's disease	3.33e-06	5.83e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NOS3—Alzheimer's disease	3.31e-06	5.8e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.31e-06	5.79e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.3e-06	5.78e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	3.3e-06	5.77e-05	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.27e-06	5.73e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	3.25e-06	5.68e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.24e-06	5.68e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.22e-06	5.64e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.22e-06	5.63e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.17e-06	5.55e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.15e-06	5.51e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.14e-06	5.49e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.12e-06	5.46e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.11e-06	5.44e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	3.09e-06	5.42e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	3.03e-06	5.3e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.98e-06	5.22e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.97e-06	5.2e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.97e-06	5.2e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—INS—Alzheimer's disease	2.91e-06	5.1e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.9e-06	5.08e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.85e-06	5e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—INS—Alzheimer's disease	2.84e-06	4.98e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.83e-06	4.96e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.82e-06	4.95e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.81e-06	4.92e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	2.8e-06	4.9e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.79e-06	4.89e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.78e-06	4.87e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	2.78e-06	4.87e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.76e-06	4.83e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.75e-06	4.82e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.74e-06	4.79e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.73e-06	4.79e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.69e-06	4.71e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—INS—Alzheimer's disease	2.68e-06	4.69e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.67e-06	4.69e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.67e-06	4.67e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.66e-06	4.65e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.63e-06	4.61e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.58e-06	4.52e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.57e-06	4.51e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.57e-06	4.51e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.57e-06	4.49e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.55e-06	4.47e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.53e-06	4.44e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.53e-06	4.42e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.52e-06	4.42e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.49e-06	4.37e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.45e-06	4.29e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.38e-06	4.17e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2.37e-06	4.16e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.35e-06	4.12e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.34e-06	4.1e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.34e-06	4.09e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.31e-06	4.05e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.28e-06	3.99e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—INS—Alzheimer's disease	2.27e-06	3.98e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.2e-06	3.86e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.19e-06	3.83e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.18e-06	3.82e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.15e-06	3.76e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.15e-06	3.76e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.08e-06	3.64e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.06e-06	3.6e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.05e-06	3.59e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.03e-06	3.56e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.99e-06	3.49e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.9e-06	3.33e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	3.19e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.8e-06	3.15e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.79e-06	3.14e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.79e-06	3.13e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.77e-06	3.09e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.75e-06	3.07e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—INS—Alzheimer's disease	1.75e-06	3.07e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.65e-06	2.89e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.64e-06	2.88e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.62e-06	2.83e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AKT1—Alzheimer's disease	1.55e-06	2.72e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.54e-06	2.69e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.52e-06	2.67e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.52e-06	2.66e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.52e-06	2.65e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.49e-06	2.61e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.41e-06	2.46e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.17e-06	2.06e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.15e-06	2.01e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.08e-06	1.89e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKT1—Alzheimer's disease	9.15e-07	1.6e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.06e-07	1.24e-05	CbGpPWpGaD
